Cerebral Glucose Metabolism and Blood Flow in Parkinson's Disease

Imaging in Parkinson's Disease

Volumn , Issue , 2011, Pages

  Ma, Yilong ^a   Peng, Shichun ^a   Dhawan, Vijay ^a   Eidelberg, David ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Cerebral blood flow; Cerebral metabolism; Functional neuroimaging; Imaging biomarkers; Metabolic brain networks; Parkinson's disease; Perfusion MRI; PET; Spect

Indexed keywords

EID: 84921259910     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195393484.003.0021     Document Type: Chapter

References (71)

1. Abe, Y., T. Kachi, T. Kato, Y. Arahata, T. Yamada, Y. Washimi et al. 2003. Occipital hypoperfusion in Parkinson's disease without dementia: Correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 74:419-22.
2. Alexander, G., and J. Moeller. 1994. Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: A principal component approach to modeling brain function in disease. Human Brain Mapping 2:1-16.
3. Asanuma, K., C. Tang, Y. Ma, V. Dhawan, P. Mattis, C. Edwards, et al. 2006. Network modulation in the treatment of Parkinson's disease. Brain 129:2667-78.
4. Bell, A. J., and T. J. Sejnowski. 1995. An information-maximization approach to blind separation and blind deconvolution. Neural Comput 7:1129-59.
5. Berti, V., C. Polito, S. Ramat, E. Vanzi, M. T. De Cristofaro, G. Pellicano et al. 2010. Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging 37:537-44.
6. Bohnen, N. I., S. Minoshima, B. Giordani, K. A. Frey, and D. E. Kuhl. 1999. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology 52:541-6.
7. Brownell, A. L., K. Canales, Y. I. Chen, B. G. Jenkins, C. Owen, E. Livni et al. 2003. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model. Neuroimage 20:1064-75.
8. Chen, K., E. M. Reiman, Z. Huan, R. J. Caselli, D. Bandy, N. Ayutyanont et al. 2009. Linking functional and structural brain images with multivariate network analyses: A novel application of the partial least square method. Neuroimage 47:602-10.
9. Davis, K. D., E. Taub, S. Houle, A. E. Lang, J. O. Dostrovsky, R. R. Tasker et al. 1997. Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med 3:671-4.
10. DeLong, M. R., and T. Wichmann. 2007. Circuits and circuit disorders of the basal ganglia. Arch Neurol 64:20-4.
11. Dhawan, V., and D. Eidelberg. 2007. PET imaging in Parkinson's disease. Curr Med Imaging Rev 3:233-41.
12. Eckert, T., K. Van Laere, C. Tang, D. E. Lewis, C. Edwards, P. Santens et al. 2007a. Quantification of Parkinson's disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging 34:496-501.
13. Eckert, T., C. Tang, and D. Eidelberg. 2007b. Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 6:926-32.
14. Eckert, T., C. Tang, Y. Ma, N. Brown, T. Lin, S. Frucht, A. Feigin, and D. Eidelberg. 2008. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 23(5):727-33.
15. Eidelberg, D. 2009. Metabolic brain networks in neurodegenerative disorders: A functional imaging approach. Trends Neurosci 32:548-57.
16. Eidelberg, D., J. R. Moeller, V. Dhawan, P. Spetsieris, S. Takikawa, T. Ishikawa et al. 1994. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14:783-801.
17. Eidelberg, D., J. R. Moeller, T. Ishikawa, V. Dhawan, P. Spetsieris, T. Chaly et al. 1995. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. J Nucl Med 1995;36:378-83.
18. Eidelberg, D., J. R. Moeller, T. Ishikawa, V. Dhawan, P. Spetsieris, D. Silbersweig et al. 1996. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol 39:450-9.
19. Eidelberg, D., J. R. Moeller, K. Kazumata, A. Antonini, D. Sterio, V. Dhawan et al. 1997. Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 120:1315-24.
20. Feigin, A., A. Antonini, M. Fukuda, R. De Notaris, R. Benti, G. Pezzoli et al. 2002. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 17:1265-70.
21. Feigin, A., M. Fukuda, V. Dhawan, S. Przedborski, V. Jackson-Lewis, M. J. Mentis et al. 2001. Metabolic correlates of levodopa response in Parkinson's disease. Neurology 57:2083-8.
22. Feigin, A., M. G. Kaplitt, C. Tang, T. Lin, P. Mattis, V. Dhawan et al. 2007. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci USA 104:19559-64.
23. Firbank, M. J., S. J. Colloby, D. J. Burn, I. G. McKeith, and J. T. O'Brien. 2003. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 20:1309-19.
24. Fukuda, M., A. Barnes, E. S. Simon, A. Holmes, V. Dhawan, N. Giladi et al. 2004. Thalamic stimulation for parkinsonian tremor: Correlation between regional cerebral blood flow and physiological tremor characteristics. Neuroimage 21:608-15.
25. Fukuda, M., M. Mentis, M. F. Ghilardi, V. Dhawan, A. Antonini, J. Hammerstad et al. 2001a. Functional correlates of pallidal stimulation for Parkinson's disease. Ann Neurol 49:155-64.
26. Fukuda, M., M. J. Mentis, Y. Ma, V. Dhawan, A. Antonini, A. E. Lang et al. 2001b. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: A PET study of resting-state glucose metabolism. Brain 124:1601-9.
27. Ghaemi, M., J. Raethjen, R. Hilker, J. Rudolf, J. Sobesky, G. Deuschl et al. 2002. Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study. Mov Disord 17:782-8.
28. Guigoni, C., S. Dovero, I. Aubert, Q. Li, B. H. Bioulac, B. Bloch et al. 2005. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. Eur J Neurosci 22:283-7.
29. Gwadry, F., C. Berenstein, J. V. Horn, A. Braun. 2001. Implementation and application of principal component analysis on functional neuroimaging data: Institute for Systems Research Technical Reports, 1-27.
30. Habeck, C., J. W. Krakauer, C. Ghez, H. A. Sackeim, D. Eidelberg, Y. Stern et al. 2005. A new approach to spatial covariance modeling of functional brain imaging data: Ordinal trend analysis. Neural Comput 17:1602-45.
31. Habeck, C., and Y. Stern. 2010. Multivariate data analysis for neuroimaging data: overview and application to Alzheimer's disease. Cell Biochem Biophys 58:53-67.
32. Hilker, R., J. Voges, S. Weisenbach, E. Kalbe, L. Burghaus, M. Ghaemi et al. 2004. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: Evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 24:7-16.
33. Hirano, S., K. Asanuma, Y. Ma, C. Tang, A. Feigin, V. Dhawan et al. 2008. Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci 28:4201-9.
34. Hosokai, Y., Y. Nishio, K. Hirayama, A. Takeda, T. Ishioka, Y. Sawada et al. 2009. Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment. Mov Disord 24:854-62.
35. Hsu, J. L., T. P. Jung, C. Y. Hsu, W. C. Hsu, Y. K. Chen, J. R. Duann et al. 2007. Regional CBF changes in Parkinson's disease: A correlation with motor dysfunction. Eur J Nucl Med Mol Imaging 34:1458-66.
36. Huang, C., P. Mattis, K. Perrine, N. Brown, V. Dhawan, and D. Eidelberg. 2008. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 70:1470-7.
37. Huang, C., P. Mattis, C. Tang, K. Perrine, M. Carbon, and D. Eidelberg. 2007a. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 34:714-23.
38. Huang, C., C. Tang, A. Feigin, M. Lesser, Y. Ma, M. Pourfar et al. 2007b. Changes in network activity with the progression of Parkinson's disease. Brain 130:1834-46.
39. Imon, Y., H. Matsuda, M. Ogawa, D. Kogure, and N. Sunohara. 1999. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 40:1583-9.
40. Jung, T.-P., S. Makeig, and M. McKeown. 2001. Imaging brain dynamics using independent component analysis. IEEE Proceedings 88:1107-22.
41. Kaasinen, V., R. P. Maguire, H. P. Hundemer, K. L. Leenders. 2006. Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease. J Neurol 253:340-8.
42. Kazumata, K., A. Antonini, V. Dhawan, J. R. Moeller, R. L. Alterman, P. Kelly et al. 1997. Preoperative indicators of clinical outcome following stereotaxic pallidotomy. Neurology 49:1083-90.
43. Kikuchi, A., A. Takeda, T. Kimpara, M. Nakagawa, R. Kawashima, M. Sugiura et al. 2001. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 193:29-36.
44. Krack, P., P. Pollak, P. Limousin, D. Hoffmann, J. Xie, A. Benazzouz et al. 1998. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 121:451-7.
45. Liepelt, I., M. Reimold, W. Maetzler, J. Godau, G. Reischl, A. Gaenslen et al. 2009. Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET. Mov Disord 24:1504-11.
46. Lin, T. P., M. Carbon, C. Tang, A. Y. Mogilner, D. Sterio, A. Beric et al. 2008. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain 131:1373-80.
47. Lozza, C., J. C. Baron, D. Eidelberg, M. J. Mentis, M. Carbon, and R. M. Marie. 2004. Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp 22:236-45.
48. Ma, Y., V. Dhawan, C. Freed, S. Fahn, and D. Eidelberg. 2005. PET and embryonic dopamine cell transplantation in Parkinson's disease. In Bioimaging in neurodegeneration, eds. P. A. Broderick, D. N. Rabni, and E. H. Kolodny, 45-58. New Jersey: Humana Press.
49. Ma, Y., and D. Eidelberg. 2007. Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease. Mol Imaging Biol 9:223-33.
50. Ma, Y., C. Huang, J. P. Dyke, H. Pan, D. Alsop, A. Feigin et al. 2010. Parkinson's disease spatial covariance pattern: Noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab 30:505-9.
51. Ma, Y., C. Tang, P. G. Spetsieris, V. Dhawan, and D. Eidelberg. 2007. Abnormal metabolic network activity in Parkinson's disease: Test-retest reproducibility. J Cereb Blood Flow Metab 27:597-605.
52. Ma, Y., C. Tang, J.R. Moeller, and D. Eidelberg. 2009. Abnormal regional brain function in Parkinson's disease: truth or fiction. NeuroImage 45:260-66.
53. Matsui, H., K. Nishinaka, M. Oda, N. Hara, K. Komatsu, T. Kubori et al. 2007. Heterogeneous factors in dementia with Parkinson's disease: IMP-SPECT study. Parkinsonism Relat Disord 13:174-81.
54. Miletich, R. S., M. Quarantelli, and G. Di Chiro. 1994. Regional cerebral blood flow imaging with 99mTc-bicisate SPECT in asymmetric Parkinson's disease: Studies with and without chronic drug therapy. J Cereb Blood Flow Metab 14 (Suppl 1):S106-14.
55. Minoshima, S., N.L. Foster, A.A. Sima, K.A. Frey, R.L. Albin, and D.E. Kuhl. 2001. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50:358-65.
56. Mure, H., S. Hirano, C. C. Tang, I. U. Isaias, A. Antonini, Y. Ma et al. 2011. Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects. Neuroimage, 54:1244-53.
57. Osaki, Y., Y. Morita, M. Fukumoto, N. Akagi, S. Yoshida, and Y. Doi. 2005. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia. Mov Disord 20:999-1005.
58. Peng, S., Y. Ma, J. Flores, D. Doudet, and D. Eidelberg. 2010. Abnormal topography of cerebral glucose metabolism in parkinsonian macaques. J Nucl Med 51(Suppl 2):1753.
59. Powers, W. J., T. O. Videen, J. Markham, K. J. Black, N. Golchin, and J. S. Perlmutter. 2008. Cerebral mitochondrial metabolism in early Parkinson's disease. J Cereb Blood Flow Metab 28:1754-60.
60. Sestini, S., S. Ramat, A. R. Formiconi, F. Ammannati, S. Sorbi, and A. Pupi. 2005. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: A 4-year follow-up study with rCBF SPECT. J Nucl Med 46:1444-54.
61. Spetsieris, P. G., and D. Eidelberg. 2011. Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues. Neuroimage 54:2899-2914.
62. Tang, C. C., and D. Eidelberg. 2010. Abnormal metabolic brain networks in Parkinson's disease: from blackboard to bedside. Prog Brain Res 184:161-76.
63. Tang, C. C., K. L. Poston, V. Dhawan, and D. Eidelberg D. 2010a. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci 30:1049-56.
64. Tang, C. C., K. L. Poston, T. Eckert, A. Feigin, S. Frucht, M. Gudesblatt et al. 2010b. Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis. Lancet Neurol 9:149-58.
65. Thobois, S., M. Jahanshahi, S. Pinto, R. Frackowiak, and P. Limousin-Dowsey. 2004. PET and SPECT functional imaging studies in parkinsonian syndromes: from the lesion to its consequences. NeuroImage 23:1-16.
66. Trost, M., S. Su, P. Su, R. F. Yen, H. M. Tseng, A. Barnes et al. 2006. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage 31:301-7.
67. Van Laere, K., P. Santens, T. Bosman, J. De Reuck, L. Mortelmans, and R. Dierckx. 2004. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: Correlation with clinical parameters. J Nucl Med 45:933-42.
68. van Laere, K., C. van der Linden, P. Santens, V. Vandewalle, J. Caemaert, P. L. Ir et al. 2000. 99Tc(m)-ECD SPET perfusion changes by internal pallidum stimulation in Parkinson's disease. Nucl Med Commun 21:1103-12.
69. Wang, J., Y. Ma, Z. Huang, B. Sun, Y. Guan, and C. Zuo. 2010. Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease. J Neurol 257:72-78.
70. Wu, J. C., R. Iacono, M. Ayman, E. Salmon, S. D. Lin, J. Carlson et al. 2000. Correlation of intellectual impairment in Parkinson's disease with FDG PET scan. Neuroreport 11:2139-44.
71. Wu, T., L. Wang, Y. Chen, C. Zhao, K. Li, and P. Chan. 2009. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease. Neurosci Lett 460:6-10.